Law360, New York (December 22, 2009, 3:23 PM EST) -- Abbott Laboratories has pounced on Sandoz Inc. in two states with allegations of patent infringement for attempting to make and market a generic version of Abbott's muscle relaxant Nimbex.
Abbott filed one complaint against Sandoz, a unit of Novartis AG, in the U.S. District Court for the District of New Jersey on Monday, and a materially identical one in the U.S. District Court for the District of Delaware on Friday.
Sandoz notified Abbott in November that it had submitted abbreviated new drug applications to the U.S....
Abbott Hits Sandoz On Generic Nimbex In Del., NJ
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
